Craig-Hallum lowered the firm’s price target on TransAct Technologies to $7.50 from $9 and keeps a Buy rating on the shares. The firm notes the stock traded down over 20% on reduced guidance that was driven by the loss of a large FST customer, which is the growth segment for the company. While Craig-Hallum believes the near-term financial pain justified a hit to the share price, the company remains in a special situation and the stock is now on sale.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TACT:
- TransAct Technologies reports preliminary Q1 EPS (10c), consensus (15c)
- TransAct Technologies Offers Clarity on Financial Results
- TransAct Technologies price target lowered to $9 from $10 at Craig-Hallum
- TransAct Technologies sees FY24 revenue $53M-$58M, two estimates $57.4M
- TransAct Technologies reports Q4 EPS (1c), two estimates (3c)